|
Article |
2 Department of Morphology, University of Geneva Medical School, 1211 Geneva Switzerland
Address correspondence to James E. Rothman, Department of Cellular Biochemistry and Biophysics, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., Box 251, New York, NY 10021. Tel.: (212) 639-8598. Fax: (212) 717-3604. email: j-rothman{at}ski.mskcc.org
![]() |
Abstract |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Key Words: Golgi; vesicles; gradient; homotypic; regulation
Abbreviations used in this paper: CGN, cis-Golgi network; i-SNARE, inhibitory SNARE; tcis, cis-Golgi t-SNARE; ttrans, trans-Golgi t-SNARE; vcis, cis-Golgi v-SNARE; vtrans, trans-Golgi v-SNARE.
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
SNARE-mediated fusion is so specific for cognate v- and t-SNAREs that the pattern of protein flow in the cell can be predicted with extraordinary accuracy based solely on the intrinsic specificity of fusion by isolated SNAREs reconstituted into artificial lipid bilayers. Of 275 tetrameric combinations of SNAREs encoded in the yeast genome (all 11 potential v-SNAREs tested with the plasma membrane, early endosomes/TGN, cis- and trans-Golgi, and vacuole t-SNAREs) tested for the capacity to fuse, only nine are fusogenic, and all but one correspond to a known transport pathway (McNew et al., 2000b; Parlati et al., 2000; Paumet et al., 2001). Therefore, the predictive power of the SNARE hypothesis for the specificity of membrane fusion (correct in at least 274/275 cases) exceeds 99% accuracy.
All of these tests of specificity have involved various combinations of isolated SNAREs allocated four at a time between two bilayers, reflecting the structural requirements of SNAREpins. Because every compartment of the secretory pathway may host a vast variety of SNAREs present in the same bilayer, we were curious as to what effect adding a fifth SNARE to the mixture of the cognate SNAREs might have. In most cases, one would anticipate no effect; however, one might imagine that in some cases the additional SNARE could effectively compete with and substitute for a fusogenic subunit, thereby inhibiting fusion. Such an inhibitory SNARE would be termed an i-SNARE. Here, we report that i-SNAREs indeed exist, and that they are likely used in the Golgi stack to fine-tune compartmental specificity.
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Therefore, there are two mutually exclusive v-SNARE/t-SNARE fusion systems operating in the Golgi stack, whose distribution has been analyzed by immuno-EM in the better-organized animal cell Golgi stacks (Volchuk et al., 2004). The cis-Golgi v- and t-SNAREs, as their name suggests, are most concentrated at the cis face of the stack, and gradually decline in concentration toward the trans face. Although the vtrans is present in a concentration gradient that increases toward the trans end of the stack, the distribution of the ttrans is likely equivalent across the Golgi stack (Volchuk et al., 2004). These findings naturally suggest a spatial segregation of the two distinct fusion processes.
To test for i-SNAREs, we examined the effect of increasing amounts of a fifth noncognate Golgi SNARE on fusion mediated by vcis + tcis and by vtrans + ttrans. The fifth SNARE (potential i-SNARE) was added on the t-SNARE side (Fig. 1 B). To compare the relative inhibitory potentials of the i-SNAREs, we establish the K50, i.e., the molar ratio of the i-SNARE to the t-SNARE needed to reduce fusion by 50% (Fig. 1 C).
|
|
|
Mechanism of action of i-SNAREs
How do i-SNAREs inhibit fusion? One possibility (competitive inhibition) is that the i-SNARE substitutes for one of the subunits of the functional tetramer, forming a nonfunctional tetrameric complex. The other possibility (noncompetitive inhibition) would be that the i-SNARE binds to the fusogenic tetramer, forming a nonfunctional oligomeric complex. In the former mechanism, the i-SNARE could compete with and substitute for a t-SNARE subunit (to form a pseudo t-SNARE that is not functional in fusion), or alternatively, it could compete with and substitute for the cognate v-SNARE (acting as a pseudo v-SNARE), thereby precluding interaction of the t-SNARE with the authentic v-SNARE.
To begin to discriminate among these possibilities, we performed a functional test to check whether a high concentration of one of the authentic t-SNARE subunits can effectively compete to suppress the inhibitory effects of the i-SNAREs (this cannot meaningfully be done with the v-SNARE because excess v-SNARE in the t-SNARE vesicle simply titrates the t-SNARE and prevents fusion). If fusion is restored by a t-SNARE subunit, then the i-SNARE acts by a competitive mechanism in which it forms a pseudo t-SNARE. If fusion is not restored by any t-SNARE subunit, then either the i-SNARE acts competitively as a pseudo v-SNARE or it forms a nonfunctional oligomer.
Fig. 4 shows the results of this analysis for the cis-Golgi fusion reaction and its i-SNAREs (Gos1, Tlg1, and Sft1). Inhibition was effectively reversed in all cases by an excess of the tcis light chain Bos1, but was not reversed by an excess of the other light chain (Sec22) or by an excess of the heavy chain (Sed5). This result establishes that all three i-SNAREs operate in the cis-Golgi fusion reaction by the same mechanismthey compete with Bos1 to form pseudo t-SNAREs (Sed5/Sec22,Gos1; Sed5/Sec22,Tlg1; Sed5/Sec22,Sft1). The tetrameric complex predicted by this mechanism (Sed5Sec22Gos1Bet1) and the trimeric complex (Sed5Sec22Sft1) have been previously reported to form with cytoplasmic domains in solution by Tsui et al. (2001). All three of these pseudo t-SNAREs have been found to be nonfusogenic with v-SNAREs tested (Parlati et al., 2002). Although the trimeric i-SNAREcontaining complexes Sed5/Sec22,Tlg1 and Sed5/Sec22,Sft1 form in solution, they are very labile, and thus may form only transiently in vivo (unpublished data). The quaternary complex Sed5Sec22Gos1Bet1 forms in solution with high efficiency, similar to the cognate cis-Golgi complex Sed5Sec22Bos1Bet1 (Tsui et al., 2001; unpublished data). To test whether this i-SNAREcontaining complex represents the "dead-end" bi-product of SNARE pairing, we examined the effect of NSF on its stability. Both Sed5Sec22Bos1Bet1 and Sed5Sec22Gos1Bet1 are disrupted in the presence of NSF and -SNAP, suggesting that both the cognate and the i-SNARE quaternary complexes are the substrates for NSF (unpublished data).
|
|
|
|
The trans preference gradient of vtrans was not much affected when either Bos1 or Bet1 were omitted, but when both were omitted, fusion with CGN rose from 4% of fusion with trans-most cisternae to
40%, and fusion of C1 rose from
5 to
55% (Fig. 7 B). Removing both Bos1 and Bet1 was similar to removing all the SNAREs other than those directly required for the trans-Golgi t-SNAREs (Sed5, Gos1, Ykt6; "trans t-SNARE only"; Fig. 7 B).
In summary, although the opposing distributions of the cis- and trans-Golgi SNAREs themselves provide for opposing distributions of the distinct fusion reactions they mediate, this predicted countercurrent fusion pattern is strongly enhanced by the opposing countercurrent distributions of the i-SNAREs. This is largely the case because the primary i-SNARE for the cis-Golgi fusion reaction is itself graded toward the trans face, whereas the primary i-SNAREs for the trans-Golgi fusion reaction is graded toward the cis face. Combining the distributions of i-SNAREs with that of the pairs of v- and t-SNAREs sharpens the predicted countercurrent pattern of membrane fusion.
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
These kinds of observations were originally interpreted as indirect evidence of the promiscuity of SNARE interactions in the fusion process, an interpretation that is no longer tenable in light of the specificity of SNARE-dependent fusion established by direct testing. This left open the question of whether the nonfusogenic complexes have a biological function or whether they are artifacts. From the present work, we suggest that the nonfusogenic complexes indeed have a biological function, which can now be explained by and indeed predicted from the discovery that certain SNAREs function as i-SNAREs. Our data on i-SNAREs suggest that nonfusogenic SNARE complexes have physiological relevance in fine-tuning the specificity of fusion. Interestingly, the recently discovered non-SNARE coiled-coil inhibitor, endosome-associated hepatocyte responsive serum phosphoprotein, has been shown to inhibit the homotypic fusion of early endosomes (Sun et al., 2003), suggesting that coiled-coilcontaining molecules may be the common regulators of membrane fusion.
i-SNAREs and the patterns of vesicle fusion in the Golgi
Although the distribution of v-SNAREs for both Golgi SNAREpins and the distribution of the tcis is in good agreement with the predicted countercurrent pattern of membrane fusion in the Golgi, the ttrans subunit Gos1 has a similar distribution throughout the Golgi and the TGN with some elevation in the CGN (Volchuk et al., 2004). The competitive nature of the i-SNAREs Gos1 and Sft1 implies that these i-SNAREs can be displaced by a sufficiently high concentration of the cognate light chain tcis Bos1 (Fig. 4). Therefore, a threefold excess of Bos1 over Gos1 present in the C1 (Volchuk et al., 2004) may be sufficient to suppress the inhibitory action of the i-SNAREs in the cis-most Golgi compartments. Thus, the ratio of an i-SNARE to its competitor Bos1, rather than the absolute i-SNARE concentration, may dictate the activity of the fusogenic gradient in the cis Golgi.
Homotypic fusion in the Golgi and the i-SNAREs
Immuno-EM data in mammalian cells indicate that the t- and v-SNAREs (as well as the potential i-SNAREs) are present both in the Golgi cisternae and vesicle membranes, raising a possibility that fusion in the Golgi has a homotypic mechanism (Volchuk et al., 2004). Therefore, complete Golgi modeling would require integration of the entire set of SNAREs both into the target and vesicle membranes. Importantly, the SNARE composition of vesicles determined in Volchuk et al. (2004) may represent an average SNARE ratio determined over many populations of vesicles, each derived from the different level of the Golgi stack. Without having the detailed information of the SNARE stoichiometry in these vesicle subpopulations, it would be very difficult to model both the target and vesicle membrane in vitro. We did test individual i-SNAREs in v-SNAREcontaining donor liposomes, and observed a very modest inhibitory effect on membrane fusion (unpublished data). Thus, the present paper should be considered as the first approximation of introducing i-SNAREs as the potential regulators of membrane fusion.
Predicted buffering capacity of the Golgi
Our previous results suggest that the two most abundant i-SNAREs in the Golgi, Sft1 for the tcis and Bet1 for the ttrans, are present at much greater molar excess than the syntaxin Sed5 in the trans Golgi and the cis Golgi, respectively (Volchuk et al., 2004). Because a fourfold molar excess of Sft1 and a twofold molar excess of Bet1 are sufficient for inhibiting 80% of the fusion activity of the tcis and ttrans, respectively (Fig. 2 and Fig. 3), these i-SNAREs exist at greater concentrations than are necessary for simple fine-tuning of the Golgi. This suggests that by maintaining high local concentrations of i-SNAREs, the Golgi may accommodate significant fluctuations in the distribution and concentration of the t-SNAREs within the stack without alteration of the countercurrent pattern of membrane fusion, thereby acting as a buffered system. As a result, the trans-Golgi fusion system may be well buffered against any fluctuations of the ttrans in the CGN. Similarly, the trans-Golgi compartments may have a high buffering capacity for the cis-Golgi fusion system. The predicted buffering capacity of the Golgi may help explain the robustness of the Golgi in vivo toward cyclic physiological and pharmacological perturbations (Lippincott-Schwartz et al., 1989; Takizawa et al., 1993; Acharya et al., 1995; Rabouille et al., 1995).
i-SNAREs outside of the Golgi
Could i-SNAREs be used outside the Golgi? The existence of certain nonfusogenic SNARE complexes involving non-Golgi SNAREs suggests this. For example, complexes of the Golgi SNAREs with endocytic SNAREs Sed5Ykt6Tlg1Vti1 and Sed5Snc2Tlg1Vti1 may represent nonfusogenic i-SNAREcontaining complexes in the TGN, which together with a fusogenic complex v-Snc/t-Tlg2/Tlg1, Vti1 may be involved in transport at the interface of endosomes and TGN (Brickner et al., 2001; Paumet et al., 2001; Tsui et al., 2001; Parlati et al., 2002). Certainly, genetic and biochemical experiments suggest that Vti1 and Tlg1 are essential both for Golgi and endocytic functions (Lupashin et al., 1997; Coe et al., 1999). We speculate that Tlg1 could function as the negative regulator of the cis- and trans-Golgi SNAREpins in the TGN, leading to inactivation of the Sed5-based SNARE complexes and simultaneous activation of the Tlg2-based SNAREpin (Paumet et al., 2001). This simultaneous switching off the Golgi SNARE machinery (required exclusively in the Golgi) and engaging endocytic SNAREs could maintain a spatial segregation of the two adjacent compartments. In addition to the TGN, a nonfusogenic complex of a vacuolar syntaxin Vam3 with the Golgi/endocytic SNAREs Vam3Vti1Tlg1Snc1 raises the possibility that i-SNAREmediated fine-tuning of membrane fusion exists throughout the secretory and endocytic pathways (Tsui et al., 2001).
![]() |
Materials and methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
SNARE reconstitution
The SNARE proteins were reconstituted into synthetic liposomes as described previously (Parlati et al., 2000). In brief, the recombinant SNAREs were mixed in 25 mM Hepes, pH 7.4, 0.4 M KCl, 1% n-octyl-ß-D-glucopyranoside, 10% glycerol, and 1 mM DTT. Before reconstitution, a soluble SNARE Ykt6 was lipid anchored with geranylgeranyl lipid as described previously (Parlati et al., 2002). 7 nmol of each SNARE protein was used for the formation of the t-SNARE complexes Sed5/Sec22, Bos1 and Sed5/Ykt6, Gos1, and v-SNAREs Bet1 and Sft1.
Modifications were made in the titration experiments as follows (Fig. 2 and Fig. 3): 7 nmol of the t-SNARE Sed5/Sec22, Bos1 was coreconstituted with increasing concentrations of the following SNAREs: GST-Gos1, Tlg1, GST-Sft1, Ykt6 (028 nmol), Vti1, and Snc1 (056 nmol). 7 nmol of the t-SNARE Sed5/Ykt6, Gos1 was coreconstituted with increasing concentrations of Bet1, Tlg1, Bos1, Sec22 (028 nmol), Vti1, and Snc1 (056 nmol). The proteoliposomes were analyzed by SDS-PAGE and Coomassie blue staining. The efficiency of protein incorporation was monitored by densitometry of individual bands with Quantity One® software (Bio-Rad Laboratories). The optical densities corrected for molecular mass were used for plotting inhibitory curves (Fig. 2 and Fig. 3).
In competition experiments (Fig. 4 and Fig. 5), the t-SNAREs were reconstituted with equimolar amounts of the i-SNAREs (7 nmol). In some cases, 35 nmol of the competing light chain or 21 nmol of a heavy chain Sed5 was added to the reconstitution reaction.
Reconstitution of the Golgi-mimetic liposomes
The Golgi-mimetic mixture of SNAREs was reconstituted into acceptor liposomes according to the standard reconstitution protocol (Weber et al., 1998). For the reconstitution experiments, we used yeast orthologues of the mammalian SNAREs at the ratios corresponding to those in the mammalian Golgi. A quantitative distribution of SNAREs in individual cisternae of the Golgi stack was previously determined with immuno-EM (Volchuk et al., 2004). The percentage of total immunogold particles for individual SNAREs in each cisternae (see Table I in Volchuk et al., 2004) was normalized to relative molar amounts of individual SNAREs in whole cells determined by quantitative immunoprecipitation (see Fig. 7 in Volchuk et al., 2004). The resulting numbers were normalized to syntaxin 5 content in every cisternae to produce the molar ratios of SNAREs in each cisternae. Because the concentration of Ykt6 in the mammalian cell was not determined, we used the average Golgi SNARE concentration in the cell (Volchuk et al., 2004). This should not pose a problem, as Ykt6 does not have i-SNARE activity. Although the distribution of Ykt6 in the mammalian Golgi was not determined by immuno-EM, immunofluorescence data indicated that Ykt6 and Gos-28 may have a similar distribution in the mammalian Golgi (Volchuk et al., 2004). Thus, we thought it would be reasonable to assume that Ykt6 and Gos-28 are present at the same ratios in the Golgi stack.
We used 7 nmol Sed5 and proportional amounts of the other SNAREs for the corresponding sets of the Golgi-mimetic liposomes. For acceptor liposomes, the estimated number of Sed5 (yeast syntaxin 5) molecules ranges from 70110 per liposome (Parlati et al., 2000, 2002). Assuming an average 45-nm diameter of acceptor liposome (surface area 5 x 10-3 µm2), the surface density of Sed5 in liposome is 18,000 molecules/µm2. The protease sensitivity test shows that typically 5070% of the reconstituted SNARE proteins are externally oriented.
Fusion assay
We performed a standard fusion assay as described previously (Weber et al., 1998). NBD fluorescence was converted to rounds of fusion as described previously (Parlati et al., 1999). 5 µg of the COOH-terminal peptides of Sft1 was added to the fusion reaction. The presence of the COOH-terminal peptides accelerates fusion reaction, but has no effect on the relative fusion values presented in this paper.
![]() |
Acknowledgments |
---|
This work was supported by grants from the National Institutes of Health (to J.E. Rothman), and from the Swiss National Science Foundation (to L. Orci). A. Volchuk was supported in part by a postdoctoral fellowship from the Medical Research Council of Canada (now the Canadian Institute of Health Research).
Submitted: 10 July 2003
Accepted: 19 November 2003
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Acharya, U., R. Jacobs, J.M. Peters, N. Watson, M.G. Farquhar, and V. Malhotra. 1995. The formation of Golgi stacks from vesiculated Golgi membranes requires two distinct fusion events. Cell. 82:895904.[Medline]
Bock, J.B., H.T. Matern, A.A. Peden, and R.H. Scheller. 2001. A genomic perspective on membrane compartment organization. Nature. 409:839841.[CrossRef][Medline]
Brickner, J.H., J.M. Blanchette, G. Sipos, and R.S. Fuller. 2001. The Tlg SNARE complex is required for TGN homotypic fusion. J. Cell Biol. 155:969978.
Coe, J.G., A.C. Lim, J. Xu, and W. Hong. 1999. A role for Tlg1p in the transport of proteins within the Golgi apparatus of Saccharomyces cerevisiae. Mol. Biol. Cell. 10:24072423.
Fasshauer, D., W. Antonin, M. Margittai, S. Pabst, and R. Jahn. 1999. Mixed and non-cognate SNARE complexes. Characterization of assembly and biophysical properties. J. Biol. Chem. 274:1544015446.
Fukuda, R., J.A. McNew, T. Weber, F. Parlati, T. Engel, W. Nickel, J.E. Rothman, and T.H. Söllner. 2000. Functional architecture of an intracellular membrane t-SNARE. Nature. 407:198202.[CrossRef][Medline]
Hardwick, K.G., and H.R. Pelham. 1992. Sed5 encodes a 39-kD integral membrane protein required for vesicular transport between the ER and the Golgi complex. J. Cell Biol. 119:513521.[Abstract]
Holthuis, J.C., B.J. Nichols, S. Dhruvakumar, and H.R. Pelham. 1998. Two syntaxin homologues in the TGN/endosomal system of yeast. EMBO J. 17:113126.
Hu, C., M. Ahmed, T.J. Melia, T.H. Söllner, T. Mayer, and J.E. Rothman. 2003. Fusion of cells by flipped SNAREs. Science. 300:17451749.
Lippincott-Schwartz, J., L.C. Yuan, J.S. Bonifacino, and R.D. Klausner. 1989. Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for membrane cycling from Golgi to ER. Cell. 56:801813.[Medline]
Lupashin, V.V., I.D. Pokrovskaya, J.A. McNew, and M.G. Waters. 1997. Characterization of a novel yeast SNARE protein implicated in Golgi retrograde traffic. Mol. Biol. Cell. 8:26592676.
McNew, J.A., M. Søgaard, N.M. Lampen, S. Machida, R.R. Ye, L. Lacomis, P. Tempst, J.E. Rothman, and T.H. Söllner. 1997. Ykt6p, a prenylated SNARE essential for endoplasmic reticulum-Golgi transport. J. Biol. Chem. 272:1777617783.
McNew, J.A., J.G. Coe, M. Søgaard, B.V. Zemelman, C. Wimmer, W. Hong, and T.H. Söllner. 1998. Gos1p, a Saccharomyces cerevisiae SNARE protein involved in Golgi transport. FEBS Lett. 435:8995.[CrossRef][Medline]
McNew, J.A., T. Weber, F. Parlati, R.J. Johnston, T.J. Melia, T.H. Söllner, and J.E. Rothman. 2000a. Close is not enough: SNARE-dependent membrane fusion requires an active mechanism that transduces force to membrane anchors. J. Cell Biol. 150:105117.
McNew, J.A., R. Fukuda, F. Parlati, R.J. Johnston, K. Paz, F. Paumet, T.H. Söllner, and J.E. Rothman. 2000b. Compartmental specificity of cellular membrane fusion encoded in SNARE proteins. Nature. 407:153159.[CrossRef][Medline]
Mollard, G.F., and T.H. Stevens. 1998. A human homolog can functionally replace the yeast vesicle-associated SNARE Vti1 in two vesicle transport pathways. J. Biol. Chem. 273:26242630.
Nichols, B.J., and H.R. Pelham. 1998. SNAREs and membrane fusion in the Golgi apparatus. Biochim. Biophys. Acta. 1404:931.[Medline]
Parlati, F., T. Weber, J.A. McNew, B. Westermann, T.H. Söllner, and J.E. Rothman. 1999. Rapid and efficient fusion of phospholipid vesicles by the alpha-helical core of a SNARE complex in the absence of an N-terminal regulatory domain. Proc. Natl. Acad. Sci. USA. 96:1256512570.
Parlati, F., J.A. McNew, R. Fukuda, R. Miller, T.H. Söllner, and J.E. Rothman. 2000. Topological restriction of SNARE-dependent membrane fusion. Nature. 407:194198.[CrossRef][Medline]
Parlati, F., O. Varlamov, K. Paz, J.A. McNew, D. Hurtado, T.H. Söllner, and J.E. Rothman. 2002. Distinct SNARE complexes mediating membrane fusion in Golgi transport based on combinatorial specificity. Proc. Natl. Acad. Sci. USA. 99:54245429.
Paumet, F., B. Brugger, F. Parlati, J.A. McNew, T.H. Söllner, and J.E. Rothman. 2001. A t-SNARE of the endocytic pathway must be activated for fusion. J. Cell Biol. 155:961968.
Protopopov, V., B. Govindan, P. Novick, and J.E. Gerst. 1993. Homologs of the synaptobrevin/VAMP family of synaptic vesicle proteins function on the late secretory pathway in S. cerevisiae. Cell. 74:855861.[Medline]
Rabouille, C., T.P. Levine, J.M. Peters, and G. Warren. 1995. An NSF-like ATPase, p97, and NSF mediate cisternal regrowth from mitotic Golgi fragments. Cell. 82:905914.[Medline]
Sun, W., Q. Yan, T.A. Vida, and A.J. Bean. 2003. Hrs regulates early endosome fusion by inhibiting formation of an endosomal SNARE complex. J. Cell Biol. 162:125137.
Sutton, R.B., D. Fasshauer, R. Jahn, and A.T. Brunger. 1998. Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 Å resolution. Nature. 395:347353.[CrossRef][Medline]
Takizawa, P.A., J.K. Yucel, B. Veit, D.J. Faulkner, T. Deerinck, G. Soto, M. Ellisman, and V. Malhotra. 1993. Complete vesiculation of Golgi membranes and inhibition of protein transport by a novel sea sponge metabolite, ilimaquinone. Cell. 73:10791090.[Medline]
Tsui, M.M., and D.K. Banfield. 2000. Yeast Golgi SNARE interactions are promiscuous. J. Cell Sci. 113:145152.
Tsui, M.M., W.C. Tai, and D.K. Banfield. 2001. Selective formation of Sed5p-containing SNARE complexes is mediated by combinatorial binding interactions. Mol. Biol. Cell. 12:521538.
Volchuk, A., M. Ravazzola, A. Perrelet, W. Eng, M. Di Liberto, O. Varlamov, M. Fukasawa, T. Engel, T.H. Söllner, J.E. Rothman, and L. Orci. 2004. Countercurrent distribution of two distinct SNARE complexes mediating transport within the Golgi stack. Mol. Biol. Cell. In press.
Weber, T., B.V. Zemelman, J.A. McNew, B. Westermann, M. Gmachl, F. Parlati, T.H. Söllner, and J.E. Rothman. 1998. SNAREpins: minimal machinery for membrane fusion. Cell. 92:759772.[Medline]
Yang, B., L. Gonzalez, Jr., R. Prekeris, M. Steegmaier, R.J. Advani, and R.H. Scheller. 1999. SNARE interactions are not selective. Implications for membrane fusion specificity. J. Biol. Chem. 274:56495653.
Zhang, T., and W. Hong. 2001. Ykt6 forms a SNARE complex with syntaxin 5, GS28, and Bet1 and participates in a late stage in endoplasmic reticulum-Golgi transport. J. Biol. Chem. 276:2748027487.
Related Article